高アンモニア血症(Hyperammonemia):グローバル臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Hyperammonemia Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hyperammonemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hyperammonemia to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hyperammonemia to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Hyperammonemia 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Hyperammonemia Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Hyperammonemia 30
Mar 10, 2014: Mecasermin treatment for Rett Syndrome is safe and well-tolerated 30
Nov 22, 2012: Neuren Completes NNZ-2566 Oral Phase I Safety Study And Files IND With FDA For Rett Syndrome 30
Nov 02, 2009: UCL (University College London) Liver Failure Group Present Two Studies On A Novel Treatment Option (OCR-002) For Complications Of Hyperammonemia In Liver Failure At The 60th Annual AASLD Meeting 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Ocera Therapeutics, Inc. 32
Clinical Trial Overview of Ocera Therapeutics, Inc. 32
Neurolixis Inc. 33
Clinical Trial Overview of Neurolixis Inc. 33
Neuren Pharmaceuticals Limited 34
Clinical Trial Overview of Neuren Pharmaceuticals Limited 34
Hyperion Therapeutics, Inc. 35
Clinical Trial Overview of Hyperion Therapeutics, Inc. 35
Edison Pharmaceuticals, Inc. 36
Clinical Trial Overview of Edison Pharmaceuticals, Inc. 36
Clinical Trial Overview of Top Institutes / Government 37
Children’s Research Institute 37
Clinical Trial Overview of Children’s Research Institute 37
Boston Children’s Hospital 38
Clinical Trial Overview of Boston Children’s Hospital 38
Faculdades Metropolitanas Unidas 39
Clinical Trial Overview of Faculdades Metropolitanas Unidas 39
University of Utah Health Care 40
Clinical Trial Overview of University of Utah Health Care 40
The Children’s Mercy Hospital 41
Clinical Trial Overview of The Children’s Mercy Hospital 41
The Children’s Hospital of Philadelphia 42
Clinical Trial Overview of The Children’s Hospital of Philadelphia 42
Assistance Publique Hopitaux De Marseille 43
Clinical Trial Overview of Assistance Publique Hopitaux De Marseille 43
The Sheba Medical Center 44
Clinical Trial Overview of The Sheba Medical Center 44
University Hospital Basel 45
Clinical Trial Overview of University Hospital Basel 45
Five Key Clinical Profiles 46
Appendix 76
Abbreviations 76
Definitions 76
Research Methodology 77
Secondary Research 77
About GlobalData 78
Contact Us 78
Disclaimer 78
Source 78


【レポート販売概要】

■ タイトル:高アンモニア血症(Hyperammonemia):グローバル臨床試験レビュー(2014年上半期)
■ 英文:Hyperammonemia Global Clinical Trials Review, H1, 2014
■ 発行日:2014年4月30日
■ 調査会社:GlobalData
■ 商品コード:GDHC2122CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。